CME: Osteoporosis Management: Advances in Pharmacotherapy
ACCREDITATION EXPIRED: July 04, 2019
Activity Description / Statement of Need:
In this online CME self-learning program:
Osteoporosis is a disease common among elderly patients that is increasing in frequency as senior citizens begin to represent a larger share of the U.S. population. Osteoporosis increases the risk of severe fracture, which, in turn, is associated with a higher risk of mortality.(3) A variety of literature has demonstrated that antiresorptive therapy is effective at reducing the progression of disease and preventing fracture; however, recent studies have demonstrated that these therapies have a variety of adverse effects,(4-11) some of which – like osteonecrosis of the jaw and atypical fractures – are severe and were unrecognized at the time of their initial FDA approval. These emerging concerns are raising questions as to the optimal duration of treatment and potential benefit of a drug holiday.
Agenda:
|
Faculty introduction, disclosures |
|
Introduction content: cursory refresher and review of osteoporosis [Learning Objective #1]
|
|
Treatment and prevention of osteoporosis [Learning Objectives #2, 3, & 4]
|
|
Summary, conclusions, and best practice recap |
Target Audience:
The following healthcare professionals: endocrinologists, geriatricians, internists; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in those areas of medicine; those who otherwise commonly care for patients with osteoporosis.
Commercial Support Disclosure: This program is supported by an educational grant from AMGEN.
Release Date: July 04, 2017 -- Expiration Date: July 04, 2019
Faculty: Yousaf Ali, MD, FACR
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Apply the results of diagnostic imaging and pertinent past medical history to determine a given patient�s diagnosis of osteoporosis or osteopenia
- Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention and apply them to a patient case
- Identify investigational pharmacotherapeutic treatments for management of osteoporosis, and describe their mechanisms of action and likely place in therapy
- Describe the challenges associated with treating patients with osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, et cetera) of the agents used to treat and prevent osteoporosis and apply** the information in optimizing patient care in a patient case
Accreditation
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Dr. Ali, MD, Associate Professor of Medicine Icahn School of Medicine at Mount Sinai, has no relevant financial disclosures.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevent financial disclosures.
Commercial Support Disclosure: This program is supported by an educational grant from AMGEN.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Male Osteoporosis Management: Advances in Pharmacotherapy
Oncology Patients at High Risk of Bone Fracture: Advances in Pharmacotherapy
Frontiers in the Pharmacotherapeutic Management of Osteoporosis